The Core Laboratory of the Marian Anderson Comprehensive Sickle Cell Center will serve as the nucleus for clinical diagnostic issues of the center and will play a pivotal role in facilitating the day-to-day management and procurement of samples for all research protocols. Select research assays will be performed in the Core. The core will assume the responsibility of providing diagnostic tests and counseling for patients followed at our center. While some of the resources will be static, that is, these resources are fully developed and can be utilized by any portion of the center or other centers, there will also be a dynamic component focusing on development of new tools as well as revisions of current techniques. Since a unique interest of the center is related to the dramatic changes in hemoglobin expression that occur during the neonatal period and first several years of life in sickle cell disease, a significant dynamic component of the core involves the measurement of fetal hemoglobin expression. Specifically, the Core Laboratory will have these objectives: I. Studies related to Hemoglobinopathy Diagnosis. II. Studies related to the Research Projects of the Center (i) Modify and refine current methods of hemoglobin characterization focusing on fetal hemoglobin. (ii) Provide analysis of various red cell characteristics (iii) Examine the polymerization potential in relation to the post-natal decline in fetal hemoglobin production III. Enhance the day-to-day mechanics of the clinically based research projects of the Center.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL062148-02
Application #
6111036
Study Section
Project Start
1999-04-01
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Dampier, Carlton; Ely, Beth; Brodecki, Darcy et al. (2014) Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease. Pediatr Blood Cancer 61:291-6
Setty, B N Yamaja; Key, Nigel S; Rao, A Koneti et al. (2012) Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis. Br J Haematol 157:370-80
Barakat, Lamia P; Patterson, Chavis A; Daniel, Lauren C et al. (2008) Quality of life among adolescents with sickle cell disease: mediation of pain by internalizing symptoms and parenting stress. Health Qual Life Outcomes 6:60
Barakat, Lamia P; Patterson, Chavis A; Weinberger, Beverley Slome et al. (2007) A prospective study of the role of coping and family functioning in health outcomes for adolescents with sickle cell disease. J Pediatr Hematol Oncol 29:752-60
Ely, Beth; Alexander, Leslie B; Reed, Monica (2005) The working alliance in pediatric chronic disease management: a pilot study of instrument reliability and feasibility. J Pediatr Nurs 20:190-200
Stuart, Marie J; Nagel, Ronald L (2004) Sickle-cell disease. Lancet 364:1343-60
Dampier, Carlton; Setty, B N Yamaja; Eggleston, Barry et al. (2004) Vaso-occlusion in children with sickle cell disease: clinical characteristics and biologic correlates. J Pediatr Hematol Oncol 26:785-90
Dampier, Carlton; Ely, Elizabeth; Eggleston, Barry et al. (2004) Physical and cognitive-behavioral activities used in the home management of sickle pain: a daily diary study in children and adolescents. Pediatr Blood Cancer 43:674-8
Sharan, K; Surrey, S; Ballas, S et al. (2004) Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease. Br J Haematol 124:240-3
Setty, B N Yamaja; Stuart, Marie J; Dampier, Carlton et al. (2003) Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet 362:1450-5

Showing the most recent 10 out of 18 publications